These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22508303)

  • 1. In vitro susceptibility of Pythium insidiosum isolates to aminoglycoside antibiotics and tigecycline.
    Mahl DL; de Jesus FP; Loreto É; Zanette RA; Ferreiro L; Pilotto MB; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2012 Jul; 56(7):4021-3. PubMed ID: 22508303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.
    Jesus FP; Ferreiro L; Loreto ÉS; Pilotto MB; Ludwig A; Bizzi K; Tondolo JS; Zanette RA; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5621-5. PubMed ID: 25001300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum.
    Jesus FP; Loreto ÉS; Ferreiro L; Alves SH; Driemeier D; Souza SO; França RT; Lopes ST; Pilotto MB; Ludwig A; Azevedo MI; Ribeiro TC; Tondolo JS; Santurio JM
    Antimicrob Agents Chemother; 2016 Jan; 60(1):87-91. PubMed ID: 26459895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the in vitro susceptibility of Pythium insidiosum.
    Loreto ES; Tondolo JS; Pilotto MB; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7534-7. PubMed ID: 25223997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of carvacrol and thymol combined with antifungals or antibacterials against Pythium insidiosum.
    Jesus FP; Ferreiro L; Bizzi KS; Loreto ÉS; Pilotto MB; Ludwig A; Alves SH; Zanette RA; Santurio JM
    J Mycol Med; 2015 Jun; 25(2):e89-93. PubMed ID: 25639921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Pythium insidiosum to macrolides and tetracycline antibiotics.
    Loreto ES; Mario DA; Denardi LB; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3588-90. PubMed ID: 21537028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenyl diselenide in vitro and in vivo activity against the oomycete Pythium insidiosum.
    Loreto ES; Alves SH; Santurio JM; Nogueira CW; Zeni G
    Vet Microbiol; 2012 Apr; 156(1-2):222-6. PubMed ID: 22055205
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Hu L; Huang X; Yee NH; Meng H; Jiang L; Liang L; Chen X
    Front Cell Infect Microbiol; 2024; 14():1430032. PubMed ID: 39268488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro anti-Pythium insidiosum activity of amorolfine hydrochloride and azithromycin, alone and in combination.
    Ianiski LB; Stibbe PC; Denardi LB; Weiblen C; Soares MP; Valente JSS; Sangioni LA; Pereira DIB; Santurio JM; Botton SA
    Med Mycol; 2021 Jan; 59(1):67-73. PubMed ID: 32400872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelation therapy as a treatment for Pythium insidiosum in an animal model.
    Zanette RA; Alves SH; Pilotto MB; Weiblen C; Fighera RA; Wolkmer P; Flores MM; Santurio JM
    J Antimicrob Chemother; 2013 May; 68(5):1144-7. PubMed ID: 23329785
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Worasilchai N; Chindamporn A; Plongla R; Torvorapanit P; Manothummetha K; Chuleerarux N; Permpalung N
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of zoospores and hyphae of Pythium insidiosum to antifungals.
    Fonseca AO; Pereira DI; Maia Filho FS; Osório LG; Maroneze BP; Valente JS; Pötter L; Meireles MC
    J Antimicrob Chemother; 2014 Jun; 69(6):1564-7. PubMed ID: 24521855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Activity of Melaleuca alternifolia (Tea Tree) in Its Free Oil and Nanoemulsion Formulations Against Pythium insidiosum.
    de Souza Silveira Valente J; de Oliveira da Silva Fonseca A; Brasil CL; Sagave L; Flores FC; de Bona da Silva C; Sangioni LA; Pötter L; Santurio JM; de Avila Botton S; Pereira DI
    Mycopathologia; 2016 Dec; 181(11-12):865-869. PubMed ID: 27544535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of the oomycete Pythium insidiosum to metallic compounds containing cadmium, lead, copper, manganese or zinc.
    Ribeiro TC; Weiblen C; Botton SA; Pereira DIB; de Jesus FPK; Verdi CM; Gressler LT; Sangioni LA; Santurio JM
    Med Mycol; 2017 Aug; 55(6):669-672. PubMed ID: 27816906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
    Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
    J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and ex vivo anti-Pythium insidiosum potential of ozonated sunflower oil.
    Braga CQ; Zambrano CG; Dos Santos Bermann C; Milech A; Ianiski LB; Soares MP; Pötter L; de Avila Botton S; Pereira DIB
    Braz J Microbiol; 2024 Mar; 55(1):867-873. PubMed ID: 37999913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Susceptibility of Pythium insidiosum to Melaleuca alternifolia, Mentha piperita and Origanum vulgare Essential Oils Combinations.
    de Souza Silveira Valente J; de Oliveira da Silva Fonseca A; Denardi LB; Dal Ben VS; de Souza Maia Filho F; Baptista CT; Braga CQ; Zambrano CG; Alves SH; de Avila Botton S; Pereira DI
    Mycopathologia; 2016 Aug; 181(7-8):617-22. PubMed ID: 27209011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.